Advanced Flower Capital (AFCG) Q1 2025 earnings summary

Executive summary

• Reported GAAP net income of $4.1 million ($0.18 per basic share) and Distributable Earnings of $4.5 million ($0.21 per basic share) for Q1 2025.

• Portfolio consisted of $366.3 million in principal across 17 loans at quarter-end, increasing to $372.5 million across 18 loans by May 1, 2025, with a weighted-average yield to maturity of ~18%.

• Paid a $0.23 per share cash dividend for Q1 2025, totaling $5.2 million, with a dividend yield of ~17%.

• The company remains highly selective in new originations due to market volatility, limited capital supply, and a disciplined investment process.

• Recent transaction: $14 million senior secured credit facility to Standard Wellness Holdings post-quarter-end.

Financial highlights

• Q1 2025 interest income was $8.5 million, down 41% year-over-year, with net interest income of $6.6 million.

• Distributable earnings totaled $4.5 million ($0.21 per share); GAAP net income was $4.1 million ($0.18 per share).

• Book value per share as of March 31, 2025, was $8.89.

• CECL reserve stood at $29.9 million (9.75% of loans at carrying value); total unrealized loss on loans at fair value was $20.4 million.

• Total assets were $321.7 million; shareholder equity was $200.8 million.

Outlook and guidance

• Originations are expected to remain muted due to market volatility and a focus on high-quality borrowers.

• Management expects continued demand for cannabis operator financing due to limited access to traditional bank capital and plans to raise additional equity and/or debt to support growth.

• Dividend policy targets 85%-100% payout over the year, with the next declaration expected around June 15.

• Cash on hand, available credit, and operating cash flows are expected to meet business needs for at least the next twelve months.

• No specific guidance on timing or proceeds from asset liquidations due to court and receiver processes.